Dr. Thomas N. Seyfried champions a metabolic perspective on cancer, highlighting glucose and glutamine as key fuels for tumor growth. His research suggests that targeting these metabolic pathways, through strategies like ketogenic diets, could inhibit cancer progression. While emphasizing evidence-based approaches, he cautions that metabolic therapies should complement, not replace, conventional treatments under expert guidance.